Literature DB >> 32236661

The world is upside down; how coronavirus changes the way we care for our patients.

Rebecca G Rogers1, Steve Swift2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32236661      PMCID: PMC7110290          DOI: 10.1007/s00192-020-04292-7

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


× No keyword cloud information.
In a week, everything changed. From busy clinics and operating rooms to phone calls and cancellations. For many of us, the change is frustrating because we feel unable to care for our patients and treat their functional problems in the light of a pandemic. Sorting through clinic and operating room schedules to see who should or should not be seen and whether or not a phone call will be sufficient care has moved our normal operating systems completely off track. As the pandemic has spread, it has affected urogynecologists across the globe. Many of us are performing virus screening, staffing obstetrics and spending many hours on the phone, reaching out to our patients. It is likely that these changes will persist for some time. If so, what will we learn from this, and how will it affect our future practice? The silver lining in all of this is that we will probably learn that a significant portion of what we do can be done remotely. For example, as previously published in the International Urogynecology Journal, we know from a randomized trial that postoperative phone visits are not inferior to in-person visits in terms of patient satisfaction, complications and adverse events [1]. Another prospective study showed that scheduled postoperative phone visits reduce the number of patient-initiated calls and < 25% of patients calling needed to be seen in person [2]. Another multicenter randomized trial established that women with overactive bladder can be treated with an anticholinergic after screening with a simple questionnaire without harm and with proved patient benefit and no in-person visit [3]. Social distancing restrictions may also prompt us to move away from “just in case” visits. We all know about these kinds of visits. For example, many surgeons have women return for an examination year after year following their surgery when they do not have symptoms. Some do not provide anticholinergic medication or vaginal estrogen refills when patients have not been for over a year; others ask women to come in person to obtain results of tests rather than giving results through a portal or phone call. Of course, a close relationship with patients offers therapeutic good, but offering care in a way that saves time, energy and money has its advantages [4]. Spending time away from the office is lonely, and it has been important to schedule online video conferencing so that educational and research missions can continue forward and we can learn from each other about how to manage clinical work in this new world. Postponement of our annual meeting was an important right step by our leadership, and we must work to continue to collaborate, network and move the science forward until we can meet again. The pace at which we are adapting is astonishing; today we participated in our first online video conference for an educational session. While not quite the same as an in-person meeting, we were able to share information, offer support to each other and, most importantly, manage our patients. In conclusion, the virus has significantly changed our immediate medical practice and will likely make some lasting changes to the way we practice urogynecology. While we navigate this uncertain time, we ultimately believe that many of these changes will improve our practice.
  3 in total

1.  Long-term efficacy and safety of questionnaire-based initiation of urgency urinary incontinence treatment.

Authors:  Rachel Hess; Alison J Huang; Holly E Richter; Chiara C Ghetti; Vivian W Sung; Elizabeth Barrett-Connor; W Thomas Gregory; JoAnn V Pinkerton; Catherine S Bradley; Stephen R Kraus; Rebecca G Rogers; Leslee L Subak; Karen C Johnson; Lily A Arya; Michael Schembri; Jeanette S Brown
Journal:  Am J Obstet Gynecol       Date:  2013-05-06       Impact factor: 8.661

2.  Follow-up postoperative calls to reduce common postoperative complaints among urogynecology patients.

Authors:  Christopher Iwanoff; Maria Giannopoulos; Charbel Salamon
Journal:  Int Urogynecol J       Date:  2018-11-09       Impact factor: 2.894

3.  Outpatient visits versus telephone interviews for postoperative care: a randomized controlled trial.

Authors:  Jennifer C Thompson; Sara B Cichowski; Rebecca G Rogers; Fares Qeadan; Julissa Zambrano; Cynthia Wenzl; Peter C Jeppson; Gena C Dunivan; Yuko M Komesu
Journal:  Int Urogynecol J       Date:  2019-02-19       Impact factor: 2.894

  3 in total
  4 in total

1.  Patient Preparedness for Pelvic Organ Prolapse Surgery: A Randomized Equivalence Trial of Preoperative Counseling.

Authors:  Jessica C Sassani; Philip J Grosse; Lauren Kunkle; Lindsey Baranski; Mary F Ackenbom
Journal:  Female Pelvic Med Reconstr Surg       Date:  2021-12-01       Impact factor: 2.091

2.  Preoperative Counseling Method and Postoperative Opioid Usage: A Secondary Analysis of the PREOP Study.

Authors:  Jessica C Sassani; Amanda M Artsen; Philip J Grosse; Lindsey Baranski; Lauren Kunkle; Mary F Ackenbom
Journal:  Female Pelvic Med Reconstr Surg       Date:  2021-03-01       Impact factor: 2.091

Review 3.  A guide for urogynecologic patient care utilizing telemedicine during the COVID-19 pandemic: review of existing evidence.

Authors:  Cara L Grimes; Ethan M Balk; Catrina C Crisp; Danielle D Antosh; Miles Murphy; Gabriela E Halder; Peter C Jeppson; Emily E Weber LeBrun; Sonali Raman; Shunaha Kim-Fine; Cheryl Iglesia; Alexis A Dieter; Ladin Yurteri-Kaplan; Gaelen Adam; Kate V Meriwether
Journal:  Int Urogynecol J       Date:  2020-04-27       Impact factor: 2.894

4.  Mental health among clinicians: what do we know and what can we do?

Authors:  Mittal Patel; Steven Swift; Alex Digesu
Journal:  Int Urogynecol J       Date:  2021-05-03       Impact factor: 1.932

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.